ANN/VIETNAM NEWS – Vietnam has rapidly positioned itself in the global veterinary vaccine industry, achieving milestones in combating critical animal diseases.
Key breakthroughs include the production of the avian influenza vaccine (Navet-Vifluvac) in 2012, the blue-ear disease vaccine in 2015, the foot-and-mouth disease vaccine in 2018, the rabies vaccine in 2019, and most notably, the African swine fever vaccine (NAVET-ASFVAC and AVAC ASF LIVE) in 2022.
Speaking at a workshop on the application of new advances in veterinary vaccines in Vietnam, held in Hanoi yesterday, Vietnam’s Head of the Department of Science, Technology and Environment under the Ministry of Agriculture and Rural Development Nguyen Thi Thanh Thuy highlighted the significance of Vietnam’s achievements. She noted that the successful production and export of the AVAC ASF LIVE vaccine by AVAC Vietnam Joint Stock Company to five countries marked a globally recognised milestone.
“With our accomplishments and growing international reputation, Vietnam is well-positioned to continue innovating and developing new vaccines to protect animal health and ensure consumer safety. By mobilising social resources and fostering enterprise participation, Vietnam’s veterinary and livestock sectors are equipped to adopt advanced technologies and create modern vaccines,” Thuy said.
The event, organised by the Department of Animal Health, the Department of Science, Technology and Environment, and Nong Nghiep Vietnam (Vietnam Agriculture) newspaper, gathered experts and businesses to exchange experiences and discuss cutting-edge scientific research.
Key topics included enhancing Vietnam’s capacity for safe and effective disease responses, optimising vaccine costs, reducing production expenses for farmers, and improving livestock quality.
Director of the Department of Animal Health Nguyen Van Long also stressed Vietnam’s readiness to collaborate internationally in the research, development, and transfer of next-generation veterinary vaccine technologies.
